Europe Healthcare Cold Chain Logistics Market Introduction and Overview
According to SPER Market Research, the Europe Healthcare Cold Chain Logistics Market is estimated to reach USD 23.98 billion by 2033 with a CAGR of 9.98%.
The report includes an in-depth analysis of the Europe Healthcare Cold Chain Logistics Market, including market size and trends, product mix, distribution channels, and supplier analysis. The specialized process of handling, shipping, and storing biologics, vaccines, and temperature-sensitive medications within a defined temperature range is known as healthcare cold chain logistics. Ensuring the effectiveness and safety of these medical items is crucial at every stage of the supply chain, from production to delivery and finally to the customer. In order to keep the products within predetermined temperature ranges and shield them from temperature excursions that could jeopardize their quality and efficacy, cold chain logistics uses refrigerated or insulated containers, temperature-controlled warehouses, and sophisticated monitoring technologies.
- February 2024: To expand its global healthcare network and provide temperature-controlled delivery solutions for medicines and healthcare supplies in the south of France, United Parcel Service (UPS) acquired the healthcare logistics section of Transports (Chabas Santé). Fifty more team members, over forty temperature-controlled cars, and storage facilities will all be added by UPS Healthcare.
- In Rotterdam, the Netherlands, Maersk started building a new cold store in November 2023. Near the Maasvlakte II port, which APM Terminals is planning to open in early 2025, is where the specialized warehouse is located.
Market Opportunities and Challenges
Opportunities: The market has grown tremendously due to advancements in technology, the region's interest in research and development, and a spike in the creation and production of biopharmaceutical vaccines and sophisticated medicines. The epidemic has led to a noticeable increase in consumer health awareness throughout Europe. Self-care has the capacity to address these issues by enabling people and creating more convenient means of obtaining healthcare. It is for these reasons that cold chain logistics for healthcare are expanding throughout Europe.
Challenges: The complex nature of storing and shipping medicines, biologics, and medical devices at temperature-sensitive levels is one of the major obstacles facing the Europe healthcare cold chain logistics market. Strict temperature control must be maintained at every stage of the supply chain, from production to delivery and distribution, in order to guarantee the effectiveness and security of medical supplies. Temperature variations that occur when these items are being transported or stored may damage them and cause them to lose their effectiveness or possibly have negative effects on patients.
Market Competitive Landscape
Because there are many players in the healthcare cold chain logistics market in Europe, it is competitive. Due to the necessity of specialized infrastructure, temperature-controlled storage facilities, and adherence to strict regulatory criteria, the healthcare cold chain logistics sector in Europe may have high entry hurdles. Germany is home to the headquarters of a number of companies in the European healthcare cold chain logistics business, including DB Schenker and Rhenus Logistics. Among the most significant participants in this market are Kuehne + Nagel and DHL International Gmbh.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Services, By End User
|
| Regions covered | Germany, France, Italy, Spain, UK, Rest of Europe
|
| Companies Covered | Alloga, Biocair, Carrier Transicold, Cavalier Logistics, DB Schenker, DHL, Envirotainer, Kuehne + Nagel, Marken Ltd, Primafrio, and other
|
COVID-19 Impact on Europe Healthcare Cold Chain Logistics Market
The Europe Healthcare Cold Chain Logistics Market has been significantly impacted by the COVID-19 pandemic, which has brought up both opportunities and problems. Cold chain logistics services are in high demand due to the pressing need to distribute vaccinations and other essential medical goods. Unprecedented problems to the healthcare cold chain were presented by ensuring the safe and effective carriage of temperature-sensitive COVID-19 vaccines, such as those that require ultra-low temperatures, such Pfizer-BioNTech's mRNA vaccine.
Key Target Audience
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturers
- Healthcare Providers
- Cold Chain Logistics Service Providers
- Regulatory Authorities
- Research Institutions
Our in-depth analysis of the Europe Healthcare Cold Chain Logistics Market includes the following segments:
|
By Product:
|
Biopharmaceuticals
Vaccines
Clinical Trial Materials
|
|
By Services:
|
Transportation
Storage
Packaging and Labelling
Others
|
|
By End User:
|
Hospitals, Clinics and Pharmaceuticals
Biopharmaceutical
Biotechnology
|
|
By Region:
|
Germany
France
Italy
Spain
UK
Rest of Europe
|
Key Topics Covered in the Report
- Europe Healthcare Cold Chain Logistics Market Size (FY’2024-FY’2033)
- Overview of Europe Healthcare Cold Chain Logistics Market
- Segmentation of Europe Healthcare Cold Chain Logistics Market By Product (Biopharmaceuticals, Vaccines, Clinical Trial Materials)
- Segmentation of Europe Healthcare Cold Chain Logistics Market By Services (Transportation, Storage, Packaging and Labelling, Others)
- Segmentation of Europe Healthcare Cold Chain Logistics Market By End User (Hospitals, Clinics and Pharmaceuticals, Biopharmaceutical, Biotechnology)
- Expansion Analysis of Europe Healthcare Cold Chain Logistics Market
- Problems and Obstacles in Europe Healthcare Cold Chain Logistics Market
- Competitive Landscape in the Europe Healthcare Cold Chain Logistics Market
- Impact of COVID-19 and Demonetization on Europe Healthcare Cold Chain Logistics Market
- Details on Current Investment in Europe Healthcare Cold Chain Logistics Market
- Competitive Analysis of Europe Healthcare Cold Chain Logistics Market
- Prominent Players in the Europe Healthcare Cold Chain Logistics Market
- SWOT Analysis of Europe Healthcare Cold Chain Logistics Market
- Europe Healthcare Cold Chain Logistics Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Healthcare Cold Chain Logistics Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Healthcare Cold Chain Logistics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Healthcare Cold Chain Logistics Market
7. Europe Healthcare Cold Chain Logistics Market, By Product (USD Million)
7.1. Europe Healthcare Cold Chain Logistics Market Value Share and Forecast, By Product, 2024-2033
7.2. Biopharmaceuticals
7.3. Vaccines
7.4. Clinical Trial Materials
8. Europe Healthcare Cold Chain Logistics Market, By Services (USD Million)
8.1. Europe Healthcare Cold Chain Logistics Market Value Share and Forecast, By Services, 2024-2033
8.2. Transportation
8.3. Storage
8.4. Packaging and Labelling
8.5. Others
9. Europe Healthcare Cold Chain Logistics Market, By End User (USD Million)
9.1. Europe Healthcare Cold Chain Logistics Market Value Share and Forecast, By End User, 2024-2033
9.2. Hospitals, Clinics and Pharmaceuticals
9.3. Biopharmaceutical
9.4. Biotechnology
10. Europe Healthcare Cold Chain Logistics Market Forecast, 2020-2033 (USD Million)
10.1. Europe Healthcare Cold Chain Logistics Market Size and Market Share
11. Europe Healthcare Cold Chain Logistics Market, By Type, 2020-2033 (USD Million)
11.1. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Product (2020-2026)
11.2. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Product (2027-2033)
12. Europe Healthcare Cold Chain Logistics Market, By Services, 2020-2033 (USD Million)
12.1. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Services (2020-2026)
12.2. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Services (2027-2033)
13. Europe Healthcare Cold Chain Logistics Market, By End User, 2020-2033 (USD Million)
13.1. Europe Healthcare Cold Chain Logistics Market Size and Market Share By End User (2020-2026)
13.2. Europe Healthcare Cold Chain Logistics Market Size and Market Share By End User (2027-2033)
14. Europe Healthcare Cold Chain Logistics Market, By Region, 2020-2033 (USD Million)
14.1. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Region (2020-2026)
14.2. Europe Healthcare Cold Chain Logistics Market Size and Market Share By Region (2027-2033)
14.3. Germany
14.4. France
14.5. Italy
14.6. Spain
14.7. UK
14.8. Rest of Europe
15. Company Profile
15.1. Alloga
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Biocair
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Carrier Transicold
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. Cavalier Logistics
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. DB Schenker
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. DHL
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. Envirotainer
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Kuehne + Nagel
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Marken Ltd
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Primafrio
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
